OREANDA-NEWS. Pharmacy chain Rigla keeps its leadership in a "Complex rating of national pharmacy chains" - rated by IMS, for 9 months 2014. According to the rating, the Rigla's market share accounted for 3,05%.

Complex pharmacy chain's rating 9 months 2014 ЁC

ЎЎ

Pharmacy chain

Location

#of POS

Market share/9M-2014

1

Rigla

Moscow

1122

3,05

2

A.V.E Group (including 36,6)

Moscow

612

2,96

3

§Ў5 Group

Moscow

992

2,48

4

Doctor Stoletov (including Ozerki)

Moscow

374

2,36

5

Imploziya* and**

Samara

1300

2,33

6

Raduga (including First aid)

S.-Petersburg

794

2,00

7

Pharmaimpex

Ijevsk

524

1,54

8

Pharmland

Ufa

470

1,17

9

Pharmacor**

S.-Petersburg

394

1,16

10

Vita

Samara

450

0,88

11

Melodia Zdoroviya

Novosibirsk

488

0,70

12

Zdorovie ludi

S.-Petersburg

220

0,45

13

Biotec**

Moscow

329

0,30

*With franchising.

**Expert estimations

*** Consolidated share growth y-o-y. Multiregional means presence in more than 3 federal regions and with turnover more than 5 bln. Rubles

Source: IMS Health

"We keep growing organically, but we are motivated to grow not only in quantity, but in high quality of new and existing pharmacies too. The pharmacy chain has been increased by 130 shops net and the number of our pharmacies will reach 1200 pharmacies at the year end", - General Director §°§°§° "Rigla" - Philippov Alexander.

Reference information: Pharmacy chain "Rigla" is a retail branch of "Protek" business, a Group of Companies. The company was founded in 2001. According to results of the 9M-2014 retail revenue of the Group reached 16,977 mln. Rubles* up 18.7% in comparison with 9M-2013. "Rigla" has been recognized "The best pharmacy chain" in professional contest "Platinum Ounce" 4 years in a row.

Unaudited results in compliance with IFRS, "Retail" segment revenue of the Group of Companies "Protek".